FDA Issues Guidance On Off-Label Info; Waxman Seeks ‘Re-examination’
This article was originally published in The Pink Sheet Daily
Executive Summary
The guidance supports long-standing policy on scientifically sound journal articles and imparts no new freedoms, device industry organization AdvaMed says.